B. Riley Has Positive Outlook for Hyperfine Q3 Earnings

Key Points

• B. Riley raised their Q3 2025 earnings estimate for Hyperfine to ($0.10) per share, up from a previous estimate of ($0.11), maintaining a "Buy" rating on the stock.
• Wells Fargo increased Hyperfine's price target from $0.68 to $0.85, while Lake Street Capital raised it from $1.50 to $2.00, also giving a "Buy" rating.
• Hyperfine reported a revenue of $2.70 million for Q2, which fell short of analysts' expectations of $3.00 million, alongside a net margin of -364.54%.

Hyperfine, Inc. (NASDAQ:HYPR - Free Report) - Analysts at B. Riley boosted their Q3 2025 earnings estimates for Hyperfine in a research report issued to clients and investors on Thursday, August 14th. B. Riley analyst Y. Zhi now expects that the company will earn ($0.10) per share for the quarter, up from their previous forecast of ($0.11). B. Riley has a "Buy" rating on the stock. The consensus estimate for Hyperfine's current full-year earnings is ($0.57) per share. B. Riley also issued estimates for Hyperfine's Q4 2025 earnings at ($0.09) EPS and FY2025 earnings at ($0.43) EPS.

Other equities analysts have also issued research reports about the company. Lake Street Capital raised their price objective on Hyperfine from $1.50 to $2.00 and gave the stock a "buy" rating in a research note on Thursday, August 14th. Wells Fargo & Company lifted their price target on shares of Hyperfine from $0.68 to $0.85 and gave the company an "equal weight" rating in a research report on Friday, August 15th. Two analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat, Hyperfine presently has an average rating of "Moderate Buy" and an average target price of $1.28.

Hyperfine Stock Performance

Hyperfine stock traded down $0.0550 during midday trading on Monday, reaching $1.2250. The stock had a trading volume of 225,362 shares, compared to its average volume of 1,422,333. The firm's fifty day simple moving average is $0.95 and its 200-day simple moving average is $0.88. Hyperfine has a 1-year low of $0.5327 and a 1-year high of $1.90. The stock has a market capitalization of $95.34 million, a P/E ratio of -2.36 and a beta of 1.06.

Hyperfine (NASDAQ:HYPR - Get Free Report) last released its quarterly earnings data on Wednesday, August 13th. The company reported ($0.12) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.12). The firm had revenue of $2.70 million during the quarter, compared to analyst estimates of $3.00 million. Hyperfine had a negative return on equity of 84.82% and a negative net margin of 364.54%. Hyperfine has set its FY 2025 guidance at EPS.

Institutional Investors Weigh In On Hyperfine

Hedge funds and other institutional investors have recently modified their holdings of the stock. EP Wealth Advisors LLC bought a new position in shares of Hyperfine in the first quarter worth approximately $25,000. Wealth Enhancement Advisory Services LLC grew its position in shares of Hyperfine by 64.3% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 82,008 shares of the company's stock valued at $72,000 after purchasing an additional 32,093 shares in the last quarter. AMH Equity Ltd bought a new stake in Hyperfine in the 1st quarter worth approximately $90,000. Finally, Renaissance Technologies LLC lifted its position in Hyperfine by 32.9% during the fourth quarter. Renaissance Technologies LLC now owns 212,300 shares of the company's stock valued at $187,000 after purchasing an additional 52,500 shares during the last quarter. 15.03% of the stock is currently owned by hedge funds and other institutional investors.

Hyperfine Company Profile

Hyperfine, Inc, a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors.